Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid
- Author
- MARRA, M1 2 ; SANTINI, D3 ; CARAGLIA, M1 2 ; TONIN, G3 ; MEO, G1 2 ; ZAPPAVIGNA, S1 2 ; FACCHINI, G4 ; MORABITO, A5 ; ABBRUZZESE, A2 ; CARTENI, G6 ; BUDILLON, A1
[1] Experimental Pharmacology Unit, National Cancer Institute Fondazione G. Pascale, Naples, Italy
[2] Department of Biochemistry and Biophysics, II University of Naples, Naples, Italy
[3] Medical Oncology, University Campus Bio-Medico, Rome, Italy
[4] Urogenital Cancer Unit, National Cancer Institute Fondazione G. Pascale, Naples, Italy
[5] Clinical Trial Unit, National Cancer Institute Fondazione G. Pascale, Naples, Italy
[6] Division of Oncology, Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Naples, Italy - Conference title
- Appropriate Patterns in Oncology. 10th GOIM National Congress
- Conference name
- Appropriate Patterns in Oncology. GOIM National Congress (10 ; Naples 2008-06-22)
- Author (monograph)
- COLUCCI, Giuseppe (Editor)1 ; CARTENI, Giacomo (Editor)2 ; MAIELLO, Evaristo (Editor)3
[1] Medical Oncology Unit, S. Carlo Hospital, Potenza, Italy
[2] Division of Oncology, A.O.R.N. A. Cardarelli, Naples, Italy
[3] Medical Oncology Unit - IRCCS Casa Sollievo della Soferenza, Viale Cappuccini 1, 71013 San Giovanni Rotondo (FG), Italy - Source
European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 79-85, 7 p ; ref : 48 ref
- ISSN
- 1359-6349
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Conference Paper
- Language
- English
- Author keyword
- Aminobisphosphonates Breast cancer Clinical activity Cyr61 Docetaxel Farnesyltransferase inhibitors Invasion Microarray Prostate cancer Zoledronic acid
- Keyword (fr)
- Acide zolédronique Activité biologique Anticancéreux Antirésorptif Cancer de la prostate Cancer du sein Cancérologie Docétaxel Farnesyl-diphosphate farnesyltransferase Inhibiteur Invasion Modèle moléculaire Métastase Pharmacologie Antimitotique Bisphosphonates Cancer Dérivé de l'acide diphosphonique Dérivé du taxane Enzyme Pathologie de l'appareil génital mâle Pathologie de l'appareil urinaire Pathologie de la glande mammaire Pathologie de la prostate Pathologie du sein Transferases Tumeur maligne
- Keyword (en)
- Zoledronic acid Biological activity Antineoplastic agent Antiresorptive agent Prostate cancer Breast cancer Cancerology Docetaxel Farnesyl-diphosphate farnesyltransferase Inhibitor Invasion Molecular model Metastasis Pharmacology Antimitotic Bisphosphonates Cancer Diphosphonic acid derivatives Taxane derivatives Enzyme Male genital diseases Urinary system disease Mammary gland diseases Prostate disease Breast disease Transferases Malignant tumor
- Keyword (es)
- Acido zoledrónico Actividad biológica Anticanceroso Antirresortivo Cáncer de la próstata Cáncer del pecho Cancerología Docetaxel Farnesyl-diphosphate farnesyltransferase Inhibidor Invasión Modelo molecular Metástasis Farmacología Antimitótico Bisfosfonatos Cáncer Difosfonico ácido derivado Taxane derivado Enzima Aparato genital macho patología Aparato urinario patología Glándula mamaria patología Prostata patología Seno patología Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20902176
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ejcsup.2008.06.023 
https://dx.doi.org/10.1016/j.ejcsup.2008.06.023
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ejcsup.2008.06.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:9:\"\u0000*\u0000jtitle\";s:45:\"European journal of cancer. Supplement (1990)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Eur. j. cancer.,Suppl. (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:2:\"79\";s:8:\"\u0000*\u0000epage\";s:2:\"85\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MARRA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:10:\"SANTINI, D\";i:1;s:11:\"CARAGLIA, M\";i:2;s:8:\"TONIN, G\";i:3;s:6:\"MEO, G\";i:4;s:13:\"ZAPPAVIGNA, S\";i:5;s:11:\"FACCHINI, G\";i:6;s:11:\"MORABITO, A\";i:7;s:13:\"ABBRUZZESE, A\";i:8;s:10:\"CARTENI, G\";i:9;s:11:\"BUDILLON, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:61:\"Appropriate Patterns in Oncology. 10th GOIM National Congress\";s:8:\"\u0000*\u0000title\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ejcsup.2008.06.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:9:\"\u0000*\u0000jtitle\";s:45:\"European journal of cancer. Supplement (1990)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Eur. j. cancer.,Suppl. (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:2:\"79\";s:8:\"\u0000*\u0000epage\";s:2:\"85\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MARRA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:10:\"SANTINI, D\";i:1;s:11:\"CARAGLIA, M\";i:2;s:8:\"TONIN, G\";i:3;s:6:\"MEO, G\";i:4;s:13:\"ZAPPAVIGNA, S\";i:5;s:11:\"FACCHINI, G\";i:6;s:11:\"MORABITO, A\";i:7;s:13:\"ABBRUZZESE, A\";i:8;s:10:\"CARTENI, G\";i:9;s:11:\"BUDILLON, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:61:\"Appropriate Patterns in Oncology. 10th GOIM National Congress\";s:8:\"\u0000*\u0000title\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ejcsup.2008.06.023\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ejcsup.2008.06.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:9:\"\u0000*\u0000jtitle\";s:45:\"European journal of cancer. Supplement (1990)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Eur. j. cancer.,Suppl. (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:2:\"79\";s:8:\"\u0000*\u0000epage\";s:2:\"85\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MARRA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:10:\"SANTINI, D\";i:1;s:11:\"CARAGLIA, M\";i:2;s:8:\"TONIN, G\";i:3;s:6:\"MEO, G\";i:4;s:13:\"ZAPPAVIGNA, S\";i:5;s:11:\"FACCHINI, G\";i:6;s:11:\"MORABITO, A\";i:7;s:13:\"ABBRUZZESE, A\";i:8;s:10:\"CARTENI, G\";i:9;s:11:\"BUDILLON, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:61:\"Appropriate Patterns in Oncology. 10th GOIM National Congress\";s:8:\"\u0000*\u0000title\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ejcsup.2008.06.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:9:\"\u0000*\u0000jtitle\";s:45:\"European journal of cancer. Supplement (1990)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Eur. j. cancer.,Suppl. (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:2:\"79\";s:8:\"\u0000*\u0000epage\";s:2:\"85\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MARRA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:10:\"SANTINI, D\";i:1;s:11:\"CARAGLIA, M\";i:2;s:8:\"TONIN, G\";i:3;s:6:\"MEO, G\";i:4;s:13:\"ZAPPAVIGNA, S\";i:5;s:11:\"FACCHINI, G\";i:6;s:11:\"MORABITO, A\";i:7;s:13:\"ABBRUZZESE, A\";i:8;s:10:\"CARTENI, G\";i:9;s:11:\"BUDILLON, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:61:\"Appropriate Patterns in Oncology. 10th GOIM National Congress\";s:8:\"\u0000*\u0000title\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ejcsup.2008.06.023\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:9:\"\u0000*\u0000jtitle\";s:45:\"European journal of cancer. Supplement (1990)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Eur. j. cancer.,Suppl. (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:1:\"6\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:2:\"79\";s:8:\"\u0000*\u0000epage\";s:2:\"85\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MARRA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:10:\"SANTINI, D\";i:1;s:11:\"CARAGLIA, M\";i:2;s:8:\"TONIN, G\";i:3;s:6:\"MEO, G\";i:4;s:13:\"ZAPPAVIGNA, S\";i:5;s:11:\"FACCHINI, G\";i:6;s:11:\"MORABITO, A\";i:7;s:13:\"ABBRUZZESE, A\";i:8;s:10:\"CARTENI, G\";i:9;s:11:\"BUDILLON, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:61:\"Appropriate Patterns in Oncology. 10th GOIM National Congress\";s:8:\"\u0000*\u0000title\";s:82:\"Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
